share_log

Louisiana State Employees Retirement System Acquires New Stake in Merit Medical Systems, Inc. (NASDAQ:MMSI)

Louisiana State Employees Retirement System Acquires New Stake in Merit Medical Systems, Inc. (NASDAQ:MMSI)

路易西安那州僱員退休系統公司收購納斯達克公司(MMSI)的新股份
Defense World ·  2022/12/31 05:11

Louisiana State Employees Retirement System acquired a new stake in Merit Medical Systems, Inc. (NASDAQ:MMSI – Get Rating) in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 27,100 shares of the medical instruments supplier's stock, valued at approximately $1,531,000.

根據路易斯安那州僱員退休系統公司提交給美國證券交易委員會的最新表格13F文件,該公司在第三季度收購了Merit Medical Systems,Inc.(微博代碼:MMSI-GET Rating)的新股份。該機構投資者購買了27,100股醫療器械供應商的股票,價值約1,531,000美元。

Several other hedge funds have also recently added to or reduced their stakes in MMSI. Eagle Asset Management Inc. raised its stake in Merit Medical Systems by 48.4% in the 2nd quarter. Eagle Asset Management Inc. now owns 712,135 shares of the medical instruments supplier's stock valued at $38,647,000 after purchasing an additional 232,211 shares during the last quarter. Assenagon Asset Management S.A. raised its stake in Merit Medical Systems by 114.2% in the 2nd quarter. Assenagon Asset Management S.A. now owns 264,292 shares of the medical instruments supplier's stock valued at $14,343,000 after purchasing an additional 140,933 shares during the last quarter. Hudson Bay Capital Management LP acquired a new stake in shares of Merit Medical Systems in the 2nd quarter worth $5,201,000. Fuller & Thaler Asset Management Inc. increased its stake in shares of Merit Medical Systems by 13.9% in the 1st quarter. Fuller & Thaler Asset Management Inc. now owns 725,079 shares of the medical instruments supplier's stock worth $48,232,000 after acquiring an additional 88,251 shares during the last quarter. Finally, ExodusPoint Capital Management LP increased its stake in shares of Merit Medical Systems by 1,457.3% in the 2nd quarter. ExodusPoint Capital Management LP now owns 88,767 shares of the medical instruments supplier's stock worth $4,817,000 after acquiring an additional 83,067 shares during the last quarter. 95.38% of the stock is owned by institutional investors and hedge funds.

其他幾家對衝基金最近也增持或減持了MMSI的股份。Eagle Asset Management Inc.在第二季度增持了48.4%的Merit Medical Systems股份。Eagle Asset Management Inc.現在持有這家醫療器械供應商的712,135股股票,價值38,647,000美元,此前該公司在上個季度又購買了232,211股票。Assenagon Asset Management S.A.在第二季度增持了114.2%的Merit Medical Systems股份。Assenagon Asset Management S.A.在上個季度額外購買了140,933股後,現在擁有這家醫療器械供應商264,292股股票,價值14,343,000美元。哈德遜灣資本管理有限公司在第二季度收購了價值5,201,000美元的Merit Medical Systems新股。Fuller&Thaler Asset Management Inc.在第一季度增持了Merit Medical Systems的股票13.9%。富勒資產管理公司(Fuller&Thaler Asset Management Inc.)在上個季度增持了88,251股後,目前持有這家醫療器械供應商725,079股股票,價值48,232,000美元。最後,ExodusPoint Capital Management LP在第二季度將其在Merit Medical Systems的股份增加了1,457.3%。ExodusPoint Capital Management LP在上個季度增持了83,067股後,現在擁有這家醫療器械供應商的88,767股股票,價值4,817,000美元。95.38%的股票由機構投資者和對衝基金持有。

Get
到達
Merit Medical Systems
優點醫療系統
alerts:
警報:

Analyst Ratings Changes

分析師評級發生變化

MMSI has been the subject of a number of recent research reports. TheStreet raised Merit Medical Systems from a "c+" rating to a "b-" rating in a research note on Friday, September 16th. Canaccord Genuity Group downgraded Merit Medical Systems from a "buy" rating to a "hold" rating and cut their target price for the stock from $73.00 to $72.00 in a research note on Tuesday, December 20th. Raymond James raised their target price on Merit Medical Systems from $71.00 to $72.00 and gave the stock an "outperform" rating in a research note on Thursday, October 27th. StockNews.com downgraded Merit Medical Systems from a "strong-buy" rating to a "buy" rating in a research note on Monday, December 26th. Finally, Canaccord Genuity Group raised their target price on Merit Medical Systems from $69.00 to $73.00 in a research note on Monday, November 7th. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat.com, Merit Medical Systems presently has an average rating of "Moderate Buy" and a consensus target price of $73.50.

MMSI是最近一些研究報告的主題。華爾街在9月16日星期五的一份研究報告中將Merit醫療系統的評級從“c+”上調至“b-”。在12月20日星期二的一份研究報告中,Canaccel Genuity Group將Merit Medical Systems的評級從買入下調至持有,並將該股的目標價從73.00美元下調至72.00美元。雷蒙德·詹姆斯在10月27日週四的一份研究報告中將Merit Medical Systems的目標價從71.00美元上調至72.00美元,並給予該股“跑贏大盤”的評級。在12月26日週一發佈的一份研究報告中,StockNews.com將Merit Medical Systems的評級從“強力買入”下調至“買入”。最後,Canaccel Genuity Group在11月7日星期一的一份研究報告中將Merit Medical Systems的目標價從69.00美元上調至73.00美元。一位分析師對該股的評級為持有,五位分析師對該股的評級為買入。根據MarketBeat.com的數據,Merit Medical Systems目前的平均評級為“中等買入”,共識目標價為73.50美元。

Merit Medical Systems Stock Performance

優點醫療系統股票表現

NASDAQ MMSI opened at $70.62 on Friday. The stock has a market cap of $4.02 billion, a PE ratio of 65.39, a P/E/G ratio of 2.46 and a beta of 1.02. The company has a current ratio of 2.35, a quick ratio of 1.19 and a debt-to-equity ratio of 0.19. Merit Medical Systems, Inc. has a twelve month low of $50.46 and a twelve month high of $76.14. The stock has a fifty day simple moving average of $69.67 and a 200-day simple moving average of $61.35.
納斯達克MMSI上週五開盤報70.62美元。該股市值為40.2億美元,市盈率為65.39倍,市盈率為2.46倍,貝塔係數為1.02。該公司的流動比率為2.35,速動比率為1.19,債務權益比率為0.19。優點醫療系統公司的股價為50.46美元的12個月低點和76.14美元的12個月高位。該股的50日簡單移動均線為69.67美元,200日簡單移動均線為61.35美元。

Merit Medical Systems (NASDAQ:MMSI – Get Rating) last released its quarterly earnings results on Wednesday, October 26th. The medical instruments supplier reported $0.64 earnings per share for the quarter, topping analysts' consensus estimates of $0.53 by $0.11. The business had revenue of $287.18 million during the quarter, compared to analysts' expectations of $273.03 million. Merit Medical Systems had a return on equity of 14.14% and a net margin of 5.43%. Equities analysts anticipate that Merit Medical Systems, Inc. will post 2.57 earnings per share for the current year.

優點醫療系統公司(納斯達克代碼:MMSI-GET Rating)最近一次發佈季度收益報告是在10月26日星期三。這家醫療器械供應商公佈本季度每股收益為0.64美元,比分析師普遍預期的0.53美元高出0.11美元。該業務本季度營收為2.8718億美元,高於分析師預期的2.7303億美元。優點醫療系統公司的股本回報率為14.14%,淨利潤率為5.43%。股票分析師預計,Merit Medical Systems,Inc.本年度每股收益將達到2.57美元。

About Merit Medical Systems

關於功德醫療系統公司

(Get Rating)

(獲取評級)

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy.

優點醫療系統公司設計、開發、製造和營銷用於介入、診斷和治療程序的一次性醫療產品,主要用於心臟病學、放射學、腫瘤學、危重護理和內窺鏡檢查。該公司在心血管和內窺鏡兩個領域開展業務。

Featured Stories

專題報道

  • Get a free copy of the StockNews.com research report on Merit Medical Systems (MMSI)
  • MarketBeat: Week in Review 12/26 – 12/30
  • The Dogs Of Tech: It's Time For A Bite Of These Stocks
  • Does This Acquisition Make Microsoft a Bear Market Buy?
  • Is Kintara Therapeutics A Hidden Gem?
  • Should You Warm up to Generac Stock for the Winter?
  • 免費獲取StockNews.com關於Merit Medical Systems(MMSI)的研究報告
  • MarketBeat:回顧一週12/26-12/30
  • 科技狗:是時候咬一口這些股票了
  • 這筆收購會讓微軟成為熊市買入者嗎?
  • 金塔拉治療公司是一顆隱藏的寶石嗎?
  • 你應該熱身到Generac股票過冬嗎?

Want to see what other hedge funds are holding MMSI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merit Medical Systems, Inc. (NASDAQ:MMSI – Get Rating).

想看看還有哪些對衝基金持有MMSI嗎?訪問HoldingsChannel.com獲取Merit Medical Systems,Inc.(納斯達克代碼:MMSI-GET Rating)的最新13F備案文件和內幕交易信息。

Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.

接受新聞和評級的優點醫療系統每日-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Merit Medical Systems和相關公司的最新新聞和分析師評級的每日簡要摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論